FDA

News and Updates by the Food and Drugs Administration (FDA)

Fedo.ai and Electronic Village Join Forces to Enhance Health Benchmarks in the GCC Region

Fedo.ai, an artificial intelligence-based platform transforming predictive health risk capabilities and empowering individuals to understand and manage their health better for emergencies, has teamed up with Electronic Village. This trailblazing entity is dedicated to promoting digital education and community development

Fedo.ai and Electronic Village Join Forces to Enhance Health Benchmarks in the GCC Region Read More »

Abbott Unveils PneumoShield 14, a New Vaccine Providing Comprehensive Protection for Children

Abbott has introduced its latest pneumococcal conjugate vaccine, PneumoShield 14, designed for children aged six weeks and older. This PCV-14 valent vaccine offers extensive coverage by protecting against the greatest number of serotypes compared to the existing PCV-10 and PCV-13

Abbott Unveils PneumoShield 14, a New Vaccine Providing Comprehensive Protection for Children Read More »

79% of Indian Pharma Executives View AI/ML as Growth Catalysts: Insights from EY Parthenon–OPPI Study

EY Parthenon (EY-P), a prominent strategy consulting entity, along with the Organisation of Pharmaceutical Producers of India (OPPI), published a report titled ‘Viksit Bharat@2047: Elevating India from Global Pharmacy to International Pharma Leader,’ charting the industry’s path towards global prominence.

79% of Indian Pharma Executives View AI/ML as Growth Catalysts: Insights from EY Parthenon–OPPI Study Read More »

Orchid Pharma and CAHO to Persist in Supporting National Initiatives Against Antimicrobial Resistance

Orchid Pharma, in collaboration with the Consortium of Accredited Healthcare Organizations (CAHO), is intensifying efforts to combat antimicrobial resistance (AMR) across India. Their joint mission is to arm healthcare practitioners with essential resources, knowledge, and education for effective antimicrobial management.

Orchid Pharma and CAHO to Persist in Supporting National Initiatives Against Antimicrobial Resistance Read More »

Biocon Biologics Collaborates with Diabetes Africa to Integrate Specialist Nursing Roles in Ethiopia

Biocon Biologics has partnered with Diabetes Africa and St Paul’s Hospital Millennium Medical College in Ethiopia to implement the ‘Embedding Specialist Nurses in Diabetes Care’ initiative. This project has resulted in a scalable approach to enhancing the skills of nursing

Biocon Biologics Collaborates with Diabetes Africa to Integrate Specialist Nursing Roles in Ethiopia Read More »

Marvel Biosciences Reveals Fresh Insights from Rett Syndrome Research, Intent on FDA Dialogues

A pre-clinical biotech company from Calgary, Marvel Biosciences Corporation, and its fully owned subsidiary Marvel Biotechnology, have shared new findings from their ongoing preclinical research on Rett syndrome. Conducted in partnership with the iBraiN Institute, these revelations offer encouraging pilot

Marvel Biosciences Reveals Fresh Insights from Rett Syndrome Research, Intent on FDA Dialogues Read More »